GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Natural product
Comment: Myxopyronin is a natural product with antibacterial activity, originally isolated from cultures of the soil-dwelling myxobacterium Myxococcus fulvus as a mixture of two components (myxopyronin A and myxopyronin B) [5]. Total synthesis has been reported [4]. We show the structure for myxopyronin B which is reported to be the component with the greater activity [5]. Functionally, it inhibits bacterial RNA polymerase [5].
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Belogurov GA, Vassylyeva MN, Sevostyanova A, Appleman JR, Xiang AX, Lira R, Webber SE, Klyuyev S, Nudler E, Artsimovitch I et al.. (2009)
Transcription inactivation through local refolding of the RNA polymerase structure. Nature, 457 (7227): 332-5. [PMID:18946472] |
|
2. Brauer M, Herrmann J, Zühlke D, Müller R, Riedel K, Sievers S. (2022)
Myxopyronin B inhibits growth of a Fidaxomicin-resistant Clostridioides difficile isolate and interferes with toxin synthesis. Gut Pathog, 14 (1): 4. [PMID:34991700] |
|
3. Doundoulakis T, Xiang AX, Lira R, Agrios KA, Webber SE, Sisson W, Aust RM, Shah AM, Showalter RE, Appleman JR et al.. (2004)
Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation. Bioorg Med Chem Lett, 14 (22): 5667-72. [PMID:15482944] |
|
4. Hu T, Schaus JV, Lam K, Palfreyman MG, Wuonola M, Gustafson G, Panek JS. (1998)
Total Synthesis and Preliminary Antibacterial Evaluation of the RNA Polymerase Inhibitors ±-Myxopyronin A and B. J. Org. Chem., 63 (7): 2401-2406. DOI: 10.1021/jo9721610 |
|
5. Irschik H, Gerth K, Höfle G, Kohl W, Reichenbach H. (1983)
The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales). J Antibiot (Tokyo), 36 (12): 1651-8. [PMID:6420386] |
|
6. Moy TI, Daniel A, Hardy C, Jackson A, Rehrauer O, Hwang YS, Zou D, Nguyen K, Silverman JA, Li Q et al.. (2011)
Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus. FEMS Microbiol Lett, 319 (2): 176-9. [PMID:21477256] |
|
7. Mukhopadhyay J, Das K, Ismail S, Koppstein D, Jang M, Hudson B, Sarafianos S, Tuske S, Patel J, Jansen R et al.. (2008)
The RNA polymerase "switch region" is a target for inhibitors. Cell, 135 (2): 295-307. [PMID:18957204] |